Mostrando 5,561 - 5,580 Resultados de 5,896 Para Buscar 'Asentiú~', tiempo de consulta: 2.19s Limitar resultados
  1. 5561
    Publicado 1996
    Tabla de Contenidos: “…Rodrigo Martinez / anon. (2:11) -- Con amores, mi madre / Juan de Anchieta (2:34) -- Pues que jamás olvidaros (5:49) ; Si abrá en este baldrés (1:27) / Juan del Enzina -- Si d'amor pena sentis / anon. (4:40) -- Tir'alla, que non quieto / Alonso (2:49) -- Todo quanto yo servi / Lope de Baena (2:21) -- Levanta Pascual / Juan del Enzina (2:53) -- Malos adalides fueron / Badajóz (5:01) -- Todos los bienes del mundo / Juan del Enzina (3:01) -- Durandarte / Francisco Millán (3:23) -- Fata la parte (2:00) ; Pedro, i bien te quiero (3:01) / Juan del Enzina -- Danza alta / Francisco de la Torre (1:44) -- Qu'es de ti, desconsolado? …”
    CD Audiom
  2. 5562
    por Jenkins, Henry, 1958-
    Publicado 2009
    Tabla de Contenidos: “…Extractos de "Matt Hills interviews Harry Jenkins" -- Star trek respuesta, reinterpretada y escrita: la escritura de los fans como caza furtiva textual -- "El normal interes femenino en las relaciones sexuales entre hombres": extractos de Terra Nostra Underground y Strange Bedfellows / Con Shoshanna Green y Cynthia Jenkins -- "Fuera del armario y dentro del universo: los homosexuales y Star Trek / con John Campbell -- "Disfrutáis haciéndonos sentir estúpidos a los demás? : alt.tv. twinpeaks, el autor embaucador y la pericia del espectador. …”
    Libro
  3. 5563
    “….: Other: Scientific Founder of Oncopep and C4 Therapeutics.; Sanofi-Aventis: Membership on an entity's Board of Directors or advisory committees.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  4. 5564
    “…Anderson:Janssen: Membership on an entity’s Board of Directors or advisory committees; Sanofi-Aventis: Membership on an entity’s Board of Directors or advisory committees; Bristol Myers Squibb: Membership on an entity’s Board of Directors or advisory committees; Oncopep and C4 Therapeutics.: Other: Scientific Founder of Oncopep and C4 Therapeutics.; Gilead: Membership on an entity’s Board of Directors or advisory committees; Celgene: Membership on an entity’s Board of Directors or advisory committees; Millenium-Takeda: Membership on an entity’s Board of Directors or advisory committees. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  5. 5565
    por Boland, M J, Felzmann, U, Giansiracusa, P J, Lucas, T G, Rassool, R P, Balazs, C, Charles, T K, Afanaciev, K, Emeliantchik, I, Ignatenko, A, Makarenko, V, Shumeiko, N, Patapenka, A, Zhuk, I, Abusleme Hoffman, A C, Diaz Gutierrez, M A, Gonzalez, M Vogel, Chi, Y, He, X, Pei, G, Pei, S, Shu, G, Wang, X, Zhang, J, Zhao, F, Zhou, Z, Chen, H, Gao, Y, Huang, W, Kuang, Y P, Li, B, Li, Y, Shao, J, Shi, J, Tang, C, Wu, X, Ma, L, Han, Y, Fang, W, Gu, Q, Huang, D, Huang, X, Tan, J, Wang, Z, Zhao, Z, Laštovička, T, Uggerhoj, U, Wistisen, T N, Aabloo, A, Eimre, K, Kuppart, K, Vigonski, S, Zadin, V, Aicheler, M, Baibuz, E, Brücken, E, Djurabekova, F, Eerola, P, Garcia, F, Haeggström, E, Huitu, K, Jansson, V, Karimaki, V, Kassamakov, I, Kyritsakis, A, Lehti, S, Meriläinen, A, Montonen, R, Niinikoski, T, Nordlund, K, Österberg, K, Parekh, M, Törnqvist, N A, Väinölä, J, Veske, M, Farabolini, W, Mollard, A, Napoly, O, Peauger, F, Plouin, J, Bambade, P, Chaikovska, I, Chehab, R, Davier, M, Kaabi, W, Kou, E, LeDiberder, F, Pöschl, R, Zerwas, D, Aimard, B, Balik, G, Baud, J-P, Blaising, J-J, Brunetti, L, Chefdeville, M, Drancourt, C, Geoffroy, N, Jacquemier, J, Jeremie, A, Karyotakis, Y, Nappa, J M, Vilalte, S, Vouters, G, Bernard, A, Peric, I, Gabriel, M, Simon, F, Szalay, M, van der Kolk, N, Alexopoulos, T, Gazis, E N, Gazis, N, Ikarios, E, Kostopoulos, V, Kourkoulis, S, Gupta, P D, Shrivastava, P, Arfaei, H, Dayyani, M K, Ghasem, H, Hajari, S S, Shaker, H, Ashkenazy, Y, Abramowicz, H, Benhammou, Y, Borysov, O, Kananov, S, Levy, A, Levy, I, Rosenblat, O, D'Auria, G, Di Mitri, S, Abe, T, Aryshev, A, Higo, T, Makida, Y, Matsumoto, S, Shidara, T, Takatomi, T, Takubo, Y, Tauchi, T, Toge, N, Ueno, K, Urakawa, J, Yamamoto, A, Yamanaka, M, Raboanary, R, Hart, R, van der Graaf, H, Eigen, G, Zalieckas, J, Adli, E, Lillestøl, R, Malina, L, Pfingstner, J, Sjobak, K N, Ahmed, W, Asghar, M I, Hoorani, H, Bugiel, S, Dasgupta, R, Firlej, M, Fiutowski, T A, Idzik, M, Kopec, M, Kuczynska, M, Moron, J, Swientek, K P, Daniluk, W, Krupa, B, Kucharczyk, M, Lesiak, T, Moszczynski, A, Pawlik, B, Sopicki, P, Wojtoń, T, Zawiejski, L, Kalinowski, J, Krawczyk, M, Żarnecki, A F, Firu, E, Ghenescu, V, Neagu, A T, Preda, T, Zgura, I-S, Aloev, A, Azaryan, N, Budagov, J, Chizhov, M, Filippova, M, Glagolev, V, Gongadze, A, Grigoryan, S, Gudkov, D, Karjavine, V, Lyablin, M, Olyunin, A, Samochkine, A, Sapronov, A, Shirkov, G, Soldatov, V, Solodko, A, Solodko, E, Trubnikov, G, Tyapkin, I, Uzhinsky, V, Vorozhtov, A, Levichev, E, Mezentsev, N, Piminov, P, Shatilov, D, Vobly, P, Zolotarev, K, Bozovic-Jelisavcic, I, Kacarevic, G, Lukic, S, Milutinovic-Dumbelovic, G, Pandurovic, M, Iriso, U, Perez, F, Pont, M, Trenado, J, Aguilar-Benitez, M, Calero, J, Garcia-Tabares, L, Gavela, D, Gutierrez, J L, Lopez, D, Toral, F, Moya, D, Ruiz-Jimeno, A, Vila, I, Argyropoulos, T, Blanch Gutierrez, C, Boronat, M, Esperante, D, Faus-Golfe, A, Fuster, J, Fuster Martinez, N, Galindo Muñoz, N, García, I, Giner Navarro, J, Ros, E, Vos, M, Brenner, R, Ekelöf, T, Jacewicz, M, Ögren, J, Olvegård, M, Ruber, R, Ziemann, V, Aguglia, D, Alipour Tehrani, N, Aloev, A, Andersson, A, Andrianala, F, Antoniou, F, Artoos, K, Atieh, S, Ballabriga Sune, R, Barnes, M J, Barranco Garcia, J, Bartosik, H, Belver-Aguilar, C, Benot Morell, A, Bett, D R, Bettoni, S, Blanchot, G, Blanco Garcia, O, Bonnin, X A, Brunner, O, Burkhardt, H, Calatroni, S, Campbell, M, Catalan Lasheras, N, Cerqueira Bastos, M, Cherif, A, Chevallay, E, Constance, B, Corsini, R, Cure, B, Curt, S, Dalena, B, Dannheim, D, De Michele, G, De Oliveira, L, Deelen, N, Delahaye, J P, Dobers, T, Doebert, S, Draper, M, Duarte Ramos, F, Dubrovskiy, A, Elsener, K, Esberg, J, Esposito, M, Fedosseev, V, Ferracin, P, Fiergolski, A, Foraz, K, Fowler, A, Friebel, F, Fuchs, J-F, Fuentes Rojas, C A, Gaddi, A, Garcia Fajardo, L, Garcia Morales, H, Garion, C, Gatignon, L, Gayde, J-C, Gerwig, H, Goldblatt, A N, Grefe, C, Grudiev, A, Guillot-Vignot, F G, Gutt-Mostowy, M L, Hauschild, M, Hessler, C, Holma, J K, Holzer, E, Hourican, M, Hynds, D, Inntjore Levinsen, Y, Jeanneret, B, Jensen, E, Jonker, M, Kastriotou, M, Kemppinen, J M K, Kieffer, R B, Klempt, W, Kononenko, O, Korsback, A, Koukovini Platia, E, Kovermann, J W, Kozsar, C-I, Kremastiotis, I, Kulis, S, Latina, A, Leaux, F, Lebrun, P, Lefevre, T, Linssen, L, Llopart Cudie, X, Maier, A A, Mainaud Durand, H, Manosperti, E, Marelli, C, Marin Lacoma, E, Martin, R, Mazzoni, S, Mcmonagle, G, Mete, O, Mether, L M, Modena, M, Münker, R M, Muranaka, T, Nebot Del Busto, E, Nikiforou, N, Nisbet, D, Nonglaton, J-M, Nuiry, F X, Nürnberg, A, Olvegard, M, Osborne, J, Papadopoulou, S, Papaphilippou, Y, Passarelli, A, Patecki, M, Pazdera, L, Pellegrini, D, Pepitone, K, Perez, F, Perez Codina, E, Perez Fontenla, A, Persson, T H B, Petrič, M, Pitters, F, Pittet, S, Plassard, F, Rajamak, R, Redford, S, Renier, Y, Rey, S F, Riddone, G, Rinolfi, L, Rodriguez Castro, E, Roloff, P, Rossi, C, Rude, V, Rumolo, G, Sailer, A, Santin, E, Schlatter, D, Schmickler, H, Schulte, D, Shipman, N, Sicking, E, Simoniello, R, Skowronski, P K, Sobrino Mompean, P, Soby, L, Sosin, M P, Sroka, S, Stapnes, S, Sterbini, G, Ström, R, Syratchev, I, Tecker, F, Thonet, P A, Timeo, L, Timko, H, Tomas Garcia, R, Valerio, P, Vamvakas, A L, Vivoli, A, Weber, M A, Wegner, R, Wendt, M, Woolley, B, Wuensch, W, Uythoven, J, Zha, H, Zisopoulos, P, Benoit, M, Vicente Barreto Pinto, M, Bopp, M, Braun, H H, Csatari Divall, M, Dehler, M, Garvey, T, Raguin, J Y, Rivkin, L, Zennaro, R, Aksoy, A, Nergiz, Z, Pilicer, E, Tapan, I, Yavas, O, Baturin, V, Kholodov, R, Lebedynskyi, S, Miroshnichenko, V, Mordyk, S, Profatilova, I, Storizhko, V, Watson, N, Winter, A, Goldstein, J, Green, S, Marshall, J S, Thomson, M A, Xu, B, Gillespie, W A, Pan, R, Tyrk, M A, Protopopescu, D, Robson, A, Apsimon, R, Bailey, I, Burt, G, Constable, D, Dexter, A, Karimian, S, Lingwood, C, Buckland, M D, Casse, G, Vossebeld, J, Bosco, A, Karataev, P, Kruchinin, K, Lekomtsev, K, Nevay, L, Snuverink, J, Yamakawa, E, Boisvert, V, Boogert, S, Boorman, G, Gibson, S, Lyapin, A, Shields, W, Teixeira-Dias, P, West, S, Jones, R, Joshi, N, Bodenstein, R, Burrows, P N, Christian, G B, Gamba, D, Perry, C, Roberts, J, Clarke, J A, Collomb, N A, Jamison, S P, Shepherd, B J A, Walsh, D, Demarteau, M, Repond, J, Weerts, H, Xia, L, Wells, J D, Adolphsen, C, Barklow, T, Breidenbach, M, Graf, N, Hewett, J., Markiewicz, T, McCormick, D, Moffeit, K, Nosochkov, Y, Oriunno, M, Phinney, N, Rizzo, T, Tantawi, S, Wang, F, Wang, J, White, G, Woodley, M
    Publicado 2016
    Enlace del recurso
    Enlace del recurso
  6. 5566
    “…Treating and managing disease: Grant No 945151), Consultant of: AB-Biotics, AbbVie, Angelini, Biogen, Boehringer-Ingelheim, Celon Pharma, Dainippon Sumitomo Pharma, Ethypharm, Ferrer, Gedeon Richter, GH Research, Glaxo-Smith Kline, Janssen, Lundbeck, Medincell, Novartis, Orion Corporation, Organon, Otsuka, Rovi, Sage, Sanofi-Aventis, Sunovion, Takeda, and Viatris, A. Murru Grant / Research support from: Spanish Ministry of Science and Innovation (PI19/00672) integrated into the Plan Nacional de I+D+I and co-financed by the ISCIII-Subdirección General de Evaluación and the Fondo Europeo de Desarrollo Regional (FEDER), Consultant of: Angelini, Idorsia, Lundbeck, Pfizer, Takeda…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  7. 5567
    “….; Bristol Myers Squibb: Membership on an entity’s Board of Directors or advisory committees; Sanofi-Aventis: Membership on an entity’s Board of Directors or advisory committees; Janssen: Membership on an entity’s Board of Directors or advisory committees; Gilead: Membership on an entity’s Board of Directors or advisory committees; Millenium-Takeda: Membership on an entity’s Board of Directors or advisory committees; Celgene: Membership on an entity’s Board of Directors or advisory committees. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  8. 5568
    “…MD, Alexion: Honoraria|AstraZeneca: Honoraria|Bavarian Nordic: Advisor/Consultant|Bavarian Nordic: Honoraria|Biogen: Honoraria|BioNTech: Board Member|BioNTech: Honoraria|GSK: Advisor/Consultant|GSK: Honoraria|Janssen-Cilag: Advisor/Consultant|Janssen-Cilag: Honoraria|Merck-Serono: Advisor/Consultant|Merck-Serono: Honoraria|Moderna: Advisor/Consultant|Moderna: Honoraria|MSD: Honoraria|Novavax: Advisor/Consultant|Novavax: Honoraria|Pfizer: Honoraria|Roche: Honoraria|Sanofi-Aventis: Honoraria|Seqirus: Advisor/Consultant|Seqirus: Honoraria|Synlab: Honoraria|Takeda: Advisor/Consultant|Takeda: Honoraria|va-Q-tec: Honoraria Richard N. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  9. 5569
    “…Cowan:  Bristol Myers Squibb: Research Funding; Secura Bio: Consultancy; Sanofi Aventis: Consultancy, Research Funding; Harpoon: Research Funding; Abbvie: Consultancy, Research Funding; Nektar: Research Funding; GSK: Consultancy; Cellectar: Consultancy; Janssen: Consultancy, Research Funding. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  10. 5570
    “…DISCLOSURES: Anderson:  Celgene: Membership on an entity's Board of Directors or advisory committees; Millenium-Takeda: Membership on an entity's Board of Directors or advisory committees; Gilead: Membership on an entity's Board of Directors or advisory committees; Janssen: Membership on an entity's Board of Directors or advisory committees; Sanofi-Aventis: Membership on an entity's Board of Directors or advisory committees; Bristol Myers Squibb: Membership on an entity's Board of Directors or advisory committees; Pfizer: Membership on an entity's Board of Directors or advisory committees; Scientific Founder of Oncopep and C4 Therapeutics: Current equity holder in publicly-traded company, Current holder of individual stocks in a privately-held company; AstraZeneca: Membership on an entity's Board of Directors or advisory committees; Mana Therapeutics: Membership on an entity's Board of Directors or advisory committees. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  11. 5571
    Publicado 2011
    Tabla de Contenidos: “…Voces de los estudiantes -- El sentir de la ciudadanía / Camila Uribe Aguado -- Una mirada a la intervención en el desplazamiento forzado / Diana Carolina Perilla Garzón -- Contradicciones de representación creadas por la publicidad / Claudia Patricia Pineda Marín.…”
    Libro
  12. 5572
  13. 5573
    “…Goldberg:  AbbVie: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding; Aprea: Research Funding; Prelude Therapeutics: Research Funding; Pfizer: Research Funding; Genentech: Consultancy, Membership on an entity's Board of Directors or advisory committees; DAVA Oncology: Honoraria; Astellas: Consultancy, Membership on an entity's Board of Directors or advisory committees; Arog: Research Funding; Celularity: Research Funding; Aptose: Consultancy, Research Funding. Anderson:  Sanofi-Aventis: Membership on an entity's Board of Directors or advisory committees; Celgene: Membership on an entity's Board of Directors or advisory committees; Gilead: Membership on an entity's Board of Directors or advisory committees; Janssen: Membership on an entity's Board of Directors or advisory committees; Bristol Myers Squibb: Membership on an entity's Board of Directors or advisory committees; Pfizer: Membership on an entity's Board of Directors or advisory committees; Millenium-Takeda: Membership on an entity's Board of Directors or advisory committees; Scientific Founder of Oncopep and C4 Therapeutics: Current equity holder in publicly-traded company, Current holder of individual stocks in a privately-held company; AstraZeneca: Membership on an entity's Board of Directors or advisory committees; Mana Therapeutics: Membership on an entity's Board of Directors or advisory committees. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  14. 5574
    “…Saeed:  Bristol-Myers Squibb Company: Consultancy; sano-aventis U.S.: Consultancy, Membership on an entity's Board of Directors or advisory committees; Janssen Pharmaceutica Products, LP: Consultancy, Other: investigator; Celgene Corporation: Consultancy, Other: investigator; MEI Pharma Inc: Consultancy, Other: investigator; Kite Pharma: Consultancy, Other: investigator; Other-TG therapeutics: Consultancy, Other: investigator; Nektar Therapeutics: Consultancy, Other: research investigator; MorphoSys AG: Consultancy, Membership on an entity's Board of Directors or advisory committees; Other-Epizyme, Inc.: Consultancy; Other-Secura Bio, Inc.: Consultancy; Seattle Genetics, Inc.: Consultancy, Membership on an entity's Board of Directors or advisory committees. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  15. 5575
    Publicado 2011
    Tabla de Contenidos: “…Forbis -- Autonomía y economía política de resistencia en Las Cañadas de Ocosingo / Richard Stahler-Sholk -- Entre el "sueño zapatista" y el "sueño americano" : la migración a Estados Unidos en una comunidad en resistencia / Alejandra Aquino Moreschi -- Visiones y sentires sobre el deterioro ambiental : un punto de partida para el manejo sustentable y la autonomía / Adriana Gómez Bonilla -- Luchas "muy otras" : reflexiones sobre procesos en marcha / Bruno Baronnet, Mariana Mora Bayo, Richard Stahler-Sholk.…”
    Libro
  16. 5576
    Publicado 1991
    Tabla de Contenidos: “…Romances aus Cancionero de palacio. Si d'amor pena sentís (5:08). O voy / Roman (1:57). Qu'es de ti, desconsolado? …”
    CD Audiom
  17. 5577
    “…Provisional Patent Application No. 62/581,175, filed N: Patents & Royalties; Calithera: Research Funding; Analysis Group: Research Funding; Sanofi/Aventis: Consultancy, Honoraria, Research Funding; Takeda: Research Funding; EMD Serono: Consultancy, Honoraria; Up-to-Date: Consultancy, Honoraria; NCCN: Consultancy, Honoraria; Lilly Oncology: Consultancy, Honoraria; Heron Therapeutics: Consultancy, Honoraria; Lancet Oncology: Honoraria; NEJM: Honoraria; American Society of Medical Oncology: Honoraria; Harborside Press: Honoraria; Navinata Healthcare: Honoraria; Platform Q: Honoraria; L-path, Kidney Cancer Journal, Clinical Care Options: Honoraria; Research to Practice: Honoraria; PeerView and PER: Honoraria; OnClive: Honoraria; Genentech: Consultancy, Honoraria, Research Funding; Ipsen: Consultancy, Honoraria, Research Funding; Tracon: Research Funding; Exelixis: Consultancy, Honoraria, Research Funding; Analysis Group: Consultancy, Honoraria; Michael J. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  18. 5578
    “…It presents a methodology that starts by evaluating and combining four SA algorithms (SenticNet, SentiStrength, Vader and BERT, being BERT trained in two datasets) to improve the quality of outputs. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  19. 5579
    “…This study aimed to evaluate the concordance of HPV results between the Sentis(TM) HPV assay (Sentis) (BGI Group, Shenzhen, China), an isothermal amplification-based HPV assay, on self-collected and clinician-collected samples and the agreement of Sentis on self-collected samples with the BD Onclarity(TM) HPV assay (Onclarity) (Becton, Dickinson, and Company, Franklin Lakes, New Jersey, USA), a PCR-based HPV assay, on clinician-collected samples. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  20. 5580
    “…Our study shows that: (1) training a model on a combination of several (training sets from several) topic-specific datasets is more effective than training a model on a topic-generic dataset; (2) the multi-task approach outperforms a single-task model when detecting both the hatefulness of a tweet and its topical focus in the context of a multi-label classification approach; and (3) the models incorporating EmoSenticNet emotions, the first level emotions of SenticNet, a blend of SenticNet and EmoSenticNet emotions or affective features based on Hurtlex, obtained the best results. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
Herramientas de búsqueda: RSS